RALEIGH, N.C. -- WasteZero, the leading provider of municipal solid waste reduction programs and supplies in the U.S., announced today that it has been selected as the official provider of specialized bags for BigBelly Solar's nationwide network of solar-powered trash compactors and recycling stations. BigBelly systems can be found in many major cities -- including New York City, Los Angeles, Boston, and Philadelphia -- as well as many large universities, such as MIT, Virginia Tech, and the California State University system.
Monday, July 21, 2014
HIGH POINT, N.C. -- TransTech Pharma, LLC recently announced that it has reached an agreement with the U.S. Food and Drug Administration Division of Neurology Products, under the Special Protocol Assessment (SPA) process, on the design of a single Phase 3 trial of TTP488 for the treatment of patients with mild Alzheimer’s disease. A Special Protocol Assessment (SPA) from the FDA is a binding agreement that the Phase 3 trial design, planned execution and statistical analyses are acceptable to support regulatory approval. Additional information regarding the FDA’s Special Protocol Assessment process may be found at: http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm080571.pdf.
It might seem strange to be in the midst of the dog days of summer talking about landing coverage in target media outlets in January, February, and March of next year, but the truth of the matter is now is the time to ramp-up PR and media relations efforts to achieve the greatest success. As I am fond of saying in articles and presentations, public relations is not brain surgery, BUT it does take planning in order to achieve the greatest return on investment. Unfortunately, a lot of times business executives without experience utilizing PR think of it as a push-button type of tool like advertising, wherein you simply buy ad space, slap an ad together and get it published. Like most things in life, the easiest efforts don't always achieve the greatest results. If you're serious about securing meaningful editorial coverage for your business, product, or service in trusted third-party media outlets your prospects and customers rely on for news and information, it will take a little more effort but the payoff will be much more significant.
Friday, July 18, 2014
CARY, N.C. -- Global Knowledge, the world’s leading IT and business skills training provider, today announced the worldwide delivery of learning services to help Business Partners build skills for SoftLayer, an IBM Company, as part of an ongoing education initiative – allowing them to maximize cloud services opportunities with their customers.
RALEIGH, N.C. -- Merz North America will establish its headquarters in Raleigh, North Carolina, officials announced at a press conference with Gov. Pat McCrory. The global pharmaceutical company – part of the Merz Pharma Group, with affiliates in 18 countries around the world – will move operations from current headquarters in Greensboro and from elsewhere in the U.S.
CARY, N.C. -- LORD Corporation MicroStrain® Sensing Systems has announced a series of enhancements to its SensorCloud™ ; cloud-based sensor data platform (http://www.SensorCloud.com). Introduced in 2011, the SensorCloud™ platform is a unique sensor data storage, visualization, and remote management platform that leverages powerful cloud computing technologies to provide excellent data scalability, rapid graphing, and user-programmable online analytics. It is currently used by numerous LORD MicroStrain® customers across a variety of industries and disciplines, including aviation, defense, oil & gas, and manufacturing.
RALEIGH, NC, LEIDEN, THE NETHERLANDS -- Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) and Pharming Group NV ( EURONEXT: PHARM) today announced that the Food and Drug Administration has approved RUCONEST® (C1 Esterase Inhibitor [Recombinant]) 50 IU/kg for the treatment of acute angioedema attacks in adult and adolescent patients with hereditary angioedema (HAE). Because of the limited number of patients with laryngeal attacks, effectiveness was not established in HAE patients with laryngeal attacks. “We are pleased that RUCONEST® provides the HAE community with another FDA-approved option for treating painful and debilitating HAE attacks,” said Anthony Castaldo, President of the Hereditary Angioedema Association (US HAEA), a non-profit patient services and research organization with a membership of over 5,000 HAE patients in the United States.
Wednesday, July 16, 2014
CHARLOTTE, N.C. -- For do-it-yourself homeowners who have wanted to install and finish drywall for their home improvement projects but weren’t sure how, National Gypsum, the maker of PURPLE® high-performance drywall products, has produced a simple step-by-step video to make it easier than ever to install and finish drywall. Featuring Anitra Mecadon, design expert and host of DIY Network’s Mega Dens, the video is available at YouTube.com/AskForPurple and can be viewed in its entirety or step-by-step.
HICKORY, N.C. -- Globally-recognized third-party logistics (3PL) provider Transportation Insight announces being named a Top 50 Domestic 3PL by Supply Chain Management Review magazine. Based on results compiled by 3PL market consultancy Armstrong & Associates, the annual list ranks 3PLs by gross logistics revenue. Transportation Insight is ranked #36, with revenues forecast to be $5 billion by January 1, 2020.
RALEIGH, N.C. -- For the fourth consecutive year, Red Hat's Customer Portal has been named one of the industry’s "Ten Best Web Support Sites” by the Association of Support Professionals (ASP). Red Hat was honored in the open division along other technology industry leaders including Cisco, Google Adwords, IBM, McAfee, Microsoft Surface Support, and PTC.
Tuesday, July 15, 2014
Targacept Phase 2b Clinical Trial in Alzheimer’s Disease Does Not Show Superiority of TC-1734 Over Donepezil
WINSTON-SALEM, N.C. -- Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics™, today announced top-line results from a Phase 2b monotherapy clinical trial of TC-1734 as a treatment for mild to moderate Alzheimer’s disease. In the trial, TC-1734 did not meet the objective of showing superiority to donepezil, the marketed medication most often prescribed for Alzheimer’s disease, after 52 weeks of treatment. The trial did not include a placebo arm and was not designed to determine whether TC-1734 is equivalent to donepezil. The co-primary endpoints for the study were measures of cognitive function and global function. Consistent with previous clinical results, TC-1734 exhibited a benign safety and tolerability profile.
RESEARCH TRIANGLE PARK, N.C. -- North Carolina’s life science community now has a new way to glean inside information that might help with funding and business strategy. It comes via the North Carolina Biotechnology Center library’s subscription to the PitchBook private equity and venture capital database. By scheduling an appointment for an in-person visit to the library, users can scour PitchBook information on more than 42,000 investors and over 200,000 deals. The library is on the second floor of NCBiotech’s headquarters in Research Triangle Park. First-time users get the first hour free. Rates vary thereafter, starting at $150 an hour.